ORCA
Online Research @ Cardiff
Browse by Current Cardiff authors
 | Up a level |
Number of items: 7.
Piggott, Luke, Silva, Ana, Robinson, Timothy, Santiago-Gomez, A., Simoes, B. M., Becker, M., Fichtner, I., Andera, L., Young, P., Morris, C., Barret-Lee, P., Alchami, F., Piva, M., Vivanco, M. d. M., Clarke, R. B., Gee, Julia M. W. and Clarkson, Richard
2018.
Acquired resistance of ER-positive breast cancer to endocrine treatment confers an adaptive sensitivity to TRAIL through post-translational downregulation of c-FLIP.
Clinical Cancer Research
24
(10)
, pp. 2452-2463.
10.1158/1078-0432.CCR-17-1381
|
     |
| Chen, Hung-Chang, Joalland, Noémie, Bridgeman, John S, Alchami, Fouad S, Jarry, Ulrich, Khan, Mohd Wajid A, Piggott, Luke, Shanneik, Yasmin, Li, Jianqiang, Herold, Marco J, Herrmann, Thomas, Price, David A., Gallimore, Awen M., Clarkson, Richard W., Scotet, Emmanuel, Moser, Bernhard and Eberl, Matthias 2017. Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8+ T cells. Immunology and Cell Biology 95 (7) , pp. 620-629. 10.1038/icb.2017.21 |
|
|
Piggott, Luke, Omidvar, Nader, Martí Pérez, Salvador, French, Rhiannon, Eberl, Matthias and Clarkson, Richard W. E.
2015.
Erratum to: Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.
Breast Cancer Research
17
(1)
, p. 96.
10.1186/s13058-015-0597-9
|
|
|
| Smalley, Matthew John, Piggott, Luke and Clarkson, Richard W. E. 2013. Breast cancer stem cells: obstacles to therapy. Cancer Letters 338 (1) , pp. 57-62. 10.1016/j.canlet.2012.04.023 |
|
|
Piggott, Luke
2012.
Investigating the therapeutic potential of cellular FLICE-like inhibitory protein and TRAIL in preclinical models of breast cancer.
PhD Thesis,
Cardiff University.
Item availability restricted. |
|
| Piggott, Luke, Omidvar, Nader, Marti-Perez, Salvador, Eberl, Matthias and Clarkson, Richard W. E. 2011. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL. Breast Cancer Research 13 (5) , R88. 10.1186/bcr2945 |
|
|
| Wakefield, A., Piggott, Luke, Croston, D., Jiang, W. G. and Clarkson, Richard W. E. 2008. Suppression of the NF-kappa B cofactor Bcl3 inhibits mammary epithelial cell apoptosis and, in breast tumours, correlates with poor prognosis. Breast Cancer Research 10 (S2) , O4. 10.1186/bcr1884 |
|
|
Cardiff University Information Services